S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Burning Rock Biotech Ltd (BNR)
Burning Rock Biotech Ltd (BNR) News

BNR

Burning Rock Biotech (BNR)

Burning Rock Biotech Ltd

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BNR

1 2 3 4 5 Next >>

Date	Time	Source	Headline	Symbol	Company
06/03/2024	5:08AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
06/02/2024	11:41PM	GlobeNewswire Inc.	Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement	NASDAQ:BNR	Burning Rock Biotech Ltd
05/30/2024	2:42AM	GlobeNewswire Inc.	Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines	NASDAQ:BNR	Burning Rock Biotech Ltd
05/29/2024	5:05AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
05/29/2024	12:34AM	GlobeNewswire Inc.	Burning Rock Reports First Quarter 2024 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
05/23/2024	1:00AM	GlobeNewswire Inc.	Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024	NASDAQ:BNR	Burning Rock Biotech Ltd
05/14/2024	5:06AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
05/14/2024	1:02AM	GlobeNewswire Inc.	Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024	NASDAQ:BNR	Burning Rock Biotech Ltd
04/29/2024	2:30AM	GlobeNewswire Inc.	Burning Rock Publishes 2023 Annual Report on Form 20-F	NASDAQ:BNR	Burning Rock Biotech Ltd
04/26/2024	12:59AM	GlobeNewswire Inc.	Burning Rock Announces ADS Ratio Change	NASDAQ:BNR	Burning Rock Biotech Ltd
03/28/2024	4:16PM	GlobeNewswire Inc.	Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
02/14/2024	11:45AM	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:BNR	Burning Rock Biotech Ltd
01/10/2024	3:08PM	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BNR	Burning Rock Biotech Ltd
01/04/2024	5:01AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
01/04/2024	12:03AM	GlobeNewswire Inc.	Burning Rock Announces Receipt of Notification from NASDAQ	NASDAQ:BNR	Burning Rock Biotech Ltd
12/20/2023	5:09AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
12/19/2023	8:35PM	GlobeNewswire Inc.	Burning Rock Announces Results of 2023 Annual General Meeting	NASDAQ:BNR	Burning Rock Biotech Ltd
11/30/2023	5:08AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
11/30/2023	12:25AM	GlobeNewswire Inc.	Burning Rock Reports Third Quarter 2023 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
11/22/2023	5:08AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
11/22/2023	1:04AM	GlobeNewswire Inc.	Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023	NASDAQ:BNR	Burning Rock Biotech Ltd
11/20/2023	7:55PM	GlobeNewswire Inc.	Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023	NASDAQ:BNR	Burning Rock Biotech Ltd
10/30/2023	2:20AM	GlobeNewswire Inc.	Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics	NASDAQ:BNR	Burning Rock Biotech Ltd
10/15/2023	6:18PM	GlobeNewswire Inc.	Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test	NASDAQ:BNR	Burning Rock Biotech Ltd
09/07/2023	9:43PM	GlobeNewswire Inc.	Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell	NASDAQ:BNR	Burning Rock Biotech Ltd
09/05/2023	5:09AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BNR	Burning Rock Biotech Ltd
08/31/2023	12:30AM	GlobeNewswire Inc.	Burning Rock Reports Second Quarter 2023 Financial Results	NASDAQ:BNR	Burning Rock Biotech Ltd
08/04/2023	2:27AM	GlobeNewswire Inc.	Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023	NASDAQ:BNR	Burning Rock Biotech Ltd
06/28/2023	3:05AM	GlobeNewswire Inc.	Burning Rock Announces Resignation and Appointment of Directors	NASDAQ:BNR	Burning Rock Biotech Ltd
06/07/2023	11:20PM	GlobeNewswire Inc.	Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of Medicine	NASDAQ:BNR	Burning Rock Biotech Ltd

Showing the most relevant articles for your search:NASDAQ:BNR

1 2 3 4 5 Next >>

HQ Global Education (CE)

Bell Buckle (PK)

Good Vibrations Shoes (PK)

ProText Mobility (PK)

Faraday Future Intellige...

Progressive Care (QB)

Clean Vision (QB)

CTR Investments and Cons... (CE)

MicroCloud Hologram

Ubiquitech Software (PK)

Decentral Life (PK)

1812 Brewing (PK)

AMC Entertainment

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions